Cargando…

Diabetic neuropathy is associated with increased pain perception, low serum beta-endorphin and increase insulin resistance among Nigerian cohorts in Ekiti State

INTRODUCTION: There has been an increase in the global prevalence of diabetic polyneuropathy and research evidence suggests that insulin resistance plays an important role in its development and prognosis. However, there seem to be a dearth of information in understanding the likely interplay betwee...

Descripción completa

Detalles Bibliográficos
Autores principales: Akintoye, Olabode O., Owoyele, Bamidele V., Fabunmi, Oyesanmi A., Raimi, Taiwo H., Oniyide, Adesola A., Akintoye, Abimbola O., Ajibare, Ayodeji J., Ajayi, David D., Adeleye, Gbenga S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7358268/
https://www.ncbi.nlm.nih.gov/pubmed/32685721
http://dx.doi.org/10.1016/j.heliyon.2020.e04377
_version_ 1783558815273189376
author Akintoye, Olabode O.
Owoyele, Bamidele V.
Fabunmi, Oyesanmi A.
Raimi, Taiwo H.
Oniyide, Adesola A.
Akintoye, Abimbola O.
Ajibare, Ayodeji J.
Ajayi, David D.
Adeleye, Gbenga S.
author_facet Akintoye, Olabode O.
Owoyele, Bamidele V.
Fabunmi, Oyesanmi A.
Raimi, Taiwo H.
Oniyide, Adesola A.
Akintoye, Abimbola O.
Ajibare, Ayodeji J.
Ajayi, David D.
Adeleye, Gbenga S.
author_sort Akintoye, Olabode O.
collection PubMed
description INTRODUCTION: There has been an increase in the global prevalence of diabetic polyneuropathy and research evidence suggests that insulin resistance plays an important role in its development and prognosis. However, there seem to be a dearth of information in understanding the likely interplay between beta endorphin, insulin resistance and pain perception especially in the setting of painful diabetic neuropathy. METHOD: This study recruited 120 volunteers divided into four groups (30 per group): group 1 healthy volunteer (control); group 2 DM type 2 without neuropathy (DM group); group 3 DM type 2 with painful neuropathy (DPN group); group 4 DM type 2 without painful neuropathy (DN). All subjects were evaluated for pain threshold and neuropathy using an ischemia-induced pain model and biothesiometer respectively. Their beta-endorphin, glycated hemoglobin, fasting plasma insulin, and HOMA values were determined and means compared using ANOVA. RESULT: Serum beta-endorphin is significantly reduced in DN and DPN (∗p < 0.001) compared with the control and DM group. Also, DPN and DN patients have significantly increased insulin resistance compared to those without neuropathy (∗p < 0.001; ∗p < 0.0001 respectively). There is a significant positive correlation between the pain threshold and beta-endorphin in all the groups except DN group. The correlation between beta-endorphin and insulin resistance was negative and significant in control and DM groups only. Suggestive that the fact that insulin resistance plays an important role in diabetes polyneuropathy, does not alone explain the chronic pain perception noticed in the DPN patients. CONCLUSION: The present study demonstrates that diabetic neuropathy patients have a poor endogenous opioid peptide system which is associated with increased pain perception and high insulin resistance. However, insulin resistance alone does not explain the chronic pain perception noticed in the DPN patients. Thus, further study is required.
format Online
Article
Text
id pubmed-7358268
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-73582682020-07-17 Diabetic neuropathy is associated with increased pain perception, low serum beta-endorphin and increase insulin resistance among Nigerian cohorts in Ekiti State Akintoye, Olabode O. Owoyele, Bamidele V. Fabunmi, Oyesanmi A. Raimi, Taiwo H. Oniyide, Adesola A. Akintoye, Abimbola O. Ajibare, Ayodeji J. Ajayi, David D. Adeleye, Gbenga S. Heliyon Article INTRODUCTION: There has been an increase in the global prevalence of diabetic polyneuropathy and research evidence suggests that insulin resistance plays an important role in its development and prognosis. However, there seem to be a dearth of information in understanding the likely interplay between beta endorphin, insulin resistance and pain perception especially in the setting of painful diabetic neuropathy. METHOD: This study recruited 120 volunteers divided into four groups (30 per group): group 1 healthy volunteer (control); group 2 DM type 2 without neuropathy (DM group); group 3 DM type 2 with painful neuropathy (DPN group); group 4 DM type 2 without painful neuropathy (DN). All subjects were evaluated for pain threshold and neuropathy using an ischemia-induced pain model and biothesiometer respectively. Their beta-endorphin, glycated hemoglobin, fasting plasma insulin, and HOMA values were determined and means compared using ANOVA. RESULT: Serum beta-endorphin is significantly reduced in DN and DPN (∗p < 0.001) compared with the control and DM group. Also, DPN and DN patients have significantly increased insulin resistance compared to those without neuropathy (∗p < 0.001; ∗p < 0.0001 respectively). There is a significant positive correlation between the pain threshold and beta-endorphin in all the groups except DN group. The correlation between beta-endorphin and insulin resistance was negative and significant in control and DM groups only. Suggestive that the fact that insulin resistance plays an important role in diabetes polyneuropathy, does not alone explain the chronic pain perception noticed in the DPN patients. CONCLUSION: The present study demonstrates that diabetic neuropathy patients have a poor endogenous opioid peptide system which is associated with increased pain perception and high insulin resistance. However, insulin resistance alone does not explain the chronic pain perception noticed in the DPN patients. Thus, further study is required. Elsevier 2020-07-11 /pmc/articles/PMC7358268/ /pubmed/32685721 http://dx.doi.org/10.1016/j.heliyon.2020.e04377 Text en © 2020 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Akintoye, Olabode O.
Owoyele, Bamidele V.
Fabunmi, Oyesanmi A.
Raimi, Taiwo H.
Oniyide, Adesola A.
Akintoye, Abimbola O.
Ajibare, Ayodeji J.
Ajayi, David D.
Adeleye, Gbenga S.
Diabetic neuropathy is associated with increased pain perception, low serum beta-endorphin and increase insulin resistance among Nigerian cohorts in Ekiti State
title Diabetic neuropathy is associated with increased pain perception, low serum beta-endorphin and increase insulin resistance among Nigerian cohorts in Ekiti State
title_full Diabetic neuropathy is associated with increased pain perception, low serum beta-endorphin and increase insulin resistance among Nigerian cohorts in Ekiti State
title_fullStr Diabetic neuropathy is associated with increased pain perception, low serum beta-endorphin and increase insulin resistance among Nigerian cohorts in Ekiti State
title_full_unstemmed Diabetic neuropathy is associated with increased pain perception, low serum beta-endorphin and increase insulin resistance among Nigerian cohorts in Ekiti State
title_short Diabetic neuropathy is associated with increased pain perception, low serum beta-endorphin and increase insulin resistance among Nigerian cohorts in Ekiti State
title_sort diabetic neuropathy is associated with increased pain perception, low serum beta-endorphin and increase insulin resistance among nigerian cohorts in ekiti state
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7358268/
https://www.ncbi.nlm.nih.gov/pubmed/32685721
http://dx.doi.org/10.1016/j.heliyon.2020.e04377
work_keys_str_mv AT akintoyeolabodeo diabeticneuropathyisassociatedwithincreasedpainperceptionlowserumbetaendorphinandincreaseinsulinresistanceamongnigeriancohortsinekitistate
AT owoyelebamidelev diabeticneuropathyisassociatedwithincreasedpainperceptionlowserumbetaendorphinandincreaseinsulinresistanceamongnigeriancohortsinekitistate
AT fabunmioyesanmia diabeticneuropathyisassociatedwithincreasedpainperceptionlowserumbetaendorphinandincreaseinsulinresistanceamongnigeriancohortsinekitistate
AT raimitaiwoh diabeticneuropathyisassociatedwithincreasedpainperceptionlowserumbetaendorphinandincreaseinsulinresistanceamongnigeriancohortsinekitistate
AT oniyideadesolaa diabeticneuropathyisassociatedwithincreasedpainperceptionlowserumbetaendorphinandincreaseinsulinresistanceamongnigeriancohortsinekitistate
AT akintoyeabimbolao diabeticneuropathyisassociatedwithincreasedpainperceptionlowserumbetaendorphinandincreaseinsulinresistanceamongnigeriancohortsinekitistate
AT ajibareayodejij diabeticneuropathyisassociatedwithincreasedpainperceptionlowserumbetaendorphinandincreaseinsulinresistanceamongnigeriancohortsinekitistate
AT ajayidavidd diabeticneuropathyisassociatedwithincreasedpainperceptionlowserumbetaendorphinandincreaseinsulinresistanceamongnigeriancohortsinekitistate
AT adeleyegbengas diabeticneuropathyisassociatedwithincreasedpainperceptionlowserumbetaendorphinandincreaseinsulinresistanceamongnigeriancohortsinekitistate